Skip to main content
Have a personal or library account? Click to login
Cardiometabolic Risk Clusters and Their Reproductive Correlates: A Latent Class Analysis of Indian Women Cover

Cardiometabolic Risk Clusters and Their Reproductive Correlates: A Latent Class Analysis of Indian Women

Open Access
|Mar 2025

References

  1. NCD Risk Factor Collaboration. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957980. DOI: 10.1016/S0140-6736(21)01330-1
  2. Liu J, Ren ZH, Qiang H, et al. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health. 2020;20(1):1415. DOI: 10.1186/s12889-020-09502-x
  3. Jaacks LM, Vandevijvere S, Pan A, et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019;7(3):231240. DOI: 10.1016/S2213-8587(19)30026-9
  4. de Lima TR, Silva DAS, Giehl MWC, D’Orsi E, González-Chica DA. Clusters of Cardiometabolic Risk Factors and Their Association with Atherosclerosis and Chronic Inflammation among Adults and Elderly in Florianópolis, Southern Brazil. Arq Bras Cardiol. 2021;117(1):3948. DOI: 10.36660/abc.20200230
  5. Wang X, Dalmeijer GW, den Ruijter HM, et al. Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study. PLoS One. 2017;12(3):e0173393. DOI: 10.1371/journal.pone.0173393
  6. Peters SAE, Wang X, Lam TH, et al. Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: results from the Asia Pacific Cohort Studies Collaboration. BMJ Open. 2018;8(3):e019335. DOI: 10.1136/bmjopen-2017-019335
  7. Biswas T, Townsend N, Gupta RD, et al. Clustering of metabolic and behavioural risk factors for cardiovascular diseases among the adult population in South and Southeast Asia: findings from WHO STEPS data. Lancet Reg Heal Southeast Asia. 2023;12:100164. DOI: 10.1016/j.lansea.2023.100164
  8. Otieno P, Asiki G, Wekesah F, et al. Multimorbidity of cardiometabolic diseases: a cross-sectional study of patterns, clusters and associated risk factors in sub-Saharan Africa. BMJ Open. 2023;13(2):e064275. DOI: 10.1136/bmjopen-2022-064275
  9. Mehata S, Shrestha N, Mehta RK, Bista B, Pandey AR, Mishra SR. Prevalence of the Metabolic Syndrome and its determinants among Nepalese adults: Findings from a nationally representative cross-sectional study. Sci Rep. 2018;8(1):14995. DOI: 10.1038/s41598-018-33177-5
  10. Okoth K, Chandan JS, Marshall T, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ. 2020;371:m3502. DOI: 10.1136/bmj.m3502
  11. Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021;143(18):e902e916. DOI: 10.1161/CIR.0000000000000961
  12. O’Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women. Circ Res. 2022;130(4):652672. DOI: 10.1161/CIRCRESAHA.121.319895
  13. Dreyfus J, Jacobs DRJ, Mueller N, et al. Age at Menarche and Cardiometabolic Risk in Adulthood: The Coronary Artery Risk Development in Young Adults Study. J Pediatr. 2015;167(2):34452.e1. DOI: 10.1016/j.jpeds.2015.04.032
  14. Day FR, Elks CE, Murray A, Ong KK, Perry JRB. Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study. Sci Rep. 2015;5:11208. DOI: 10.1038/srep11208
  15. Tørris C, Bjørnnes AK. Duration of Lactation and Maternal Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2020;12(9). DOI: 10.3390/nu12092718
  16. Chung E, Kim Y, Usen O. Associations Between Parity, Obesity, and Cardiovascular Risk Factors Among Middle-Aged Women. J Womens Health (Larchmt). 2016;25(8):818825. DOI: 10.1089/jwh.2015.5581
  17. Moazzeni SS, Hizomi Arani R, Asgari S, Azizi F, Hadaegh F. The association of parity/live birth number with incident type 2 diabetes among women: over 15 years of follow-up in The Tehran Lipid and Glucose Study. BMC Womens Health. 2021;21(1):378. DOI: 10.1186/s12905-021-01519-7
  18. Gijsberts CM, Groenewegen KA, Hoefer IE, et al. Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events. PLoS One. 2015;10(7):e0132321. DOI: 10.1371/journal.pone.0132321
  19. Patel SA, Shivashankar R, Ali MK, et al. Is the “South Asian Phenotype” Unique to South Asians?: Comparing Cardiometabolic Risk Factors in the CARRS and NHANES Studies. Glob Heart. 2016;11(1):8996.e3. DOI: 10.1016/j.gheart.2015.12.010
  20. Luhar S, Timæus IM, Jones R, et al. Forecasting the prevalence of overweight and obesity in India to 2040. PLoS One. 2020;15(2):e0229438. DOI: 10.1371/journal.pone.0229438
  21. Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69(11):29322938. DOI: 10.4103/ijo.IJO_1627_21
  22. International Institute for Population Sciences (IIPS), ICF. National Family Health Survey (NFHS-5), 2019–21. IIPS;2021. Available from: https://dhsprogram.com/pubs/pdf/FR375/FR375.pdf.
  23. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pr. Hypertension. 2018;71(6):e13e115. DOI: 10.1161/HYP.0000000000000065
  24. American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2021;45(Supplement_1):S17S38. DOI: 10.2337/dc22-S002
  25. World Health Organization. The WHO STEPwise Approach to Noncommunicable Disease Risk Factor Surveillance. Vol 36; 2017. https://www.who.int/docs/default-source/ncds/ncd-surveillance/steps/steps-manual.pdf?sfvrsn=c281673d_5.
  26. Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci (Landmark Ed.). 2019;24(5):890934. DOI: 10.2741/4758
  27. Bubach S, Horta BL, Gonçalves H, Assunção MCF. Early age at menarche and metabolic cardiovascular risk factors: mediation by body composition in adulthood. Sci Rep. 2021;11(1):148. DOI: 10.1038/s41598-020-80496-7
  28. Kim Y, Je Y. Early Menarche and Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. J Womens Health (Larchmt). 2019;28(1):7786. DOI: 10.1089/jwh.2018.6998
  29. Yang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20(2):133138. DOI: 10.1097/MNH.0b013e3283431921
  30. Farahmand M, Ramezani Tehrani F, Behboudi Gandevani S, Azizi F. Is There any Association between Age at Menarche and Risk of Metabolic Syndrome? The Tehran Lipid & Glucose Study. Arch Iran Med. 2019;22(9):495500.
  31. Ibitoye M, Choi C, Tai H, Lee G, Sommer M. Early menarche: A systematic review of its effect on sexual and reproductive health in low- and middle-income countries. PLoS One. 2017;12(6):e0178884. DOI: 10.1371/journal.pone.0178884
  32. Horn J, Tanz LJ, Stuart JJ, et al. Early or late pregnancy loss and development of clinical cardiovascular disease risk factors: a prospective cohort study. BJOG. 2019;126(1):3342. DOI: 10.1111/1471-0528.15452
  33. Tsulukidze M, Reardon D, Craver C. Elevated cardiovascular disease risk in low-income women with a history of pregnancy loss. Open Hear. 2022;9(1). DOI: 10.1136/openhrt-2022-002035
  34. Shufelt C, LeVee A. Hormonal Contraception in Women With Hypertension. JAMA. 2020;324(14):14511452. DOI: 10.1001/jama.2020.11935
  35. Ibrahim H, Tengku Ismail TA, Hashim N. Comparison of body weight among hormonal and non-hormonal users in a Malaysian cohort. J Taibah Univ Med Sci. 2019;14(1):2530. DOI: 10.1016/j.jtumed.2018.11.012
  36. Mosorin ME, Haverinen A, Ollila MM, et al. Current use of combined hormonal contraception is associated with glucose metabolism disorders in perimenopausal women. Eur J Endocrinol. 2020;183(6):619626. DOI: 10.1530/EJE-20-0406
  37. Cameron NA, Blyler CA, Bello NA. Oral Contraceptive Pills and Hypertension: A Review of Current Evidence and Recommendations. Hypertension. 2023;80(5):924935. DOI: 10.1161/HYPERTENSIONAHA.122.20018
  38. Reardon DC. The abortion and mental health controversy: A comprehensive literature review of common ground agreements, disagreements, actionable recommendations, and research opportunities. SAGE open Med. 2018;6:2050312118807624. DOI: 10.1177/2050312118807624
  39. World Health Organization & United Nations Population Fund. Mental health aspects of women’s reproductive health: a global review of the literature. Published online 2009. Available from: https://iris.who.int/handle/10665/43846.
  40. Magidson J, Vermunt J. Latent class models for clustering: A comparison with K-means. Can J Mark Res. 2002;20(1):3643.
DOI: https://doi.org/10.5334/gh.1408 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 9, 2024
Accepted on: Feb 13, 2025
Published on: Mar 11, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Wilhemina Quarpong, Suchitra Chandrasekaran, K. M. Venkat Narayan, Usha Ramakrishnan, Nikhil Tandon, Shivani A. Patel, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.